ArticleKidney international reports2021

Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab.

Orhan Efe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.